Innovent Biologics' 2nd NDA for Diabetes Drug Accepted by Chinese Regulator Innovent Biologics' (HKG:1801) second new drug application (NDA) for mazdutide has been accepted by China's National Medical...
Source LinkInnovent Biologics' 2nd NDA for Diabetes Drug Accepted by Chinese Regulator Innovent Biologics' (HKG:1801) second new drug application (NDA) for mazdutide has been accepted by China's National Medical...
Source Link
Comments